# William A. Gahl, MD, PhD – FDA Inspection, Dec 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/william-a-gahl-md-phd/87deb270-062c-4007-8b1f-4c568232ad14
Source feed: FDA_Inspections

> FDA inspection 1257044 of William A. Gahl, MD, PhD, December 19, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257044
- Company Name: William A. Gahl, MD, PhD
- Inspection Date: 2024-12-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Baltimore District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 673146 - 2010-07-08](https://www.keypedia.com/records/fda_inspections/william-a-gahl-md-phd/2f28a7f3-c92f-46c6-bdf0-deb895f970b0)

## Related Officers

- [Investigator](https://www.keypedia.com/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)
- [Lucilla Facchin](https://www.keypedia.com/people/lucilla-facchin/e5c5c863-b2f4-44a8-8093-d1cb4f71949b)

Company: https://www.keypedia.com/companies/william-a-gahl-md-phd/8c7e9558-5b83-407b-8d44-a0c934c9c84e

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa
